All programs

Completed

I3 – Investing in Innovation Africa

Scaling innovations that improve access to healthcare across Africa

I3 is a pan-African initiative supporting innovative health businesses in commercializing their solutions, expanding market access and building high-impact partnerships.

Turning innovation into market access

I3 connects innovative health businesses with the organizations that can accelerate their growth, including healthcare organizations, governments, donors, industry leaders and strategic partners.

The initiative combines funding, market access and partnership facilitation to help selected companies turn innovation into solutions deployed at greater scale.

Four levers to scale

  • Introductions to healthcare organizations, governments, donors and private-sector players to accelerate the adoption of solutions.

  • Access to funding designed to reduce risk and enable companies to develop new partnerships and growth opportunities.

  • Support on strategic positioning, opportunity preparation and closing commercial or institutional partnerships.

  • Showcasing innovations and entrepreneurs to strengthen their visibility and help remove barriers faced by the ecosystem.

Selected companies from the cohort

A selection of innovative companies supported through the I3 program.

  • Deepecho

  • LifeBank

  • DrugStoc

  • Viebeg Technologies

  • ClinicPesa

  • Cure Bionics

  • Sobrus

  • Meditect

  • Xetova

  • Zuri Health

  • Chekkit

  • Gricd

  • Medsaf

  • OneHealth

  • Aviro Health

  • Zinacare

A landscape of health innovation

  • Digital Health & Telemedicine

  • Pharmaceutical Distribution & Supply Chain

  • Diagnostics & MedTech

  • Health Financing

  • Data & Health Infrastructure

  • Pharmacy & Last-Mile Access

Partners

I3 is supported by an international network of partners committed to health innovation, market access and scaling solutions that improve access to healthcare across Africa.

  • Gates Foundation